Yamei Li
- Pharmacology top 5%
- Pharmacological Effects of Natural Compounds 7
-
- Natural product bioactivities and synthesis 17
- Metabolomics and Mass Spectrometry Studies 6
- Gut microbiota and health 5
- RNA modifications and cancer 4
- Biotechnology top 10%
- Enzyme Production and Characterization 4
-
- Traditional Chinese Medicine Analysis 5
-
- Cancer-related molecular mechanisms research 4
- Journals
- Analytical Chemistry (1 paper)The FASEB Journal (1 paper)Journal of Experimental Botany (1 paper)
- Partner nations
- ChinaSaudi ArabiaEgypt
In The Last Decade
Yamei Li
67 papers receiving 804 citations
Peers
Comparison fields: 5 of 100
- Pharmacology 90
- Molecular Biology 543
- Biotechnology 67
- Complementary and alternative medicine 55
- Biochemistry 38
Countries citing papers authored by Yamei Li
This map shows the geographic impact of Yamei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yamei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yamei Li more than expected).
Fields of papers citing papers by Yamei Li
This network shows the impact of papers produced by Yamei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yamei Li. The network helps show where Yamei Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yamei Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 7 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 1 | |
| 6 | 2025 | 0 | |
| 7 | 2024 | 6 | |
| 8 | 2024 | 4 | |
| 9 | 2024 | 0 | |
| 10 | 2024 | 4 | |
| 11 | 2024 | 1 | |
| 12 | 2023 | 23 | |
| 13 | 2023 | 16 | |
| 14 | 2023 | 5 | |
| 15 | 2022 | 9 | |
| 16 | 2022 | 23 | |
| 17 | 2022 | 2 | |
| 18 | 2021 | 5 | |
| 19 | 2018 | 16 | |
| 20 | 2017 | 3 |
About Yamei Li
Yamei Li is a scholar working on Pharmacology, Complementary and alternative medicine and Molecular Biology, having authored 72 papers that have together received 812 indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (17 papers), Pharmacological Effects of Natural Compounds (7 papers), Metabolomics and Mass Spectrometry Studies (6 papers), Traditional Chinese Medicine Analysis (5 papers), Gut microbiota and health (5 papers), RNA modifications and cancer (4 papers), Enzyme Production and Characterization (4 papers) and Cancer-related molecular mechanisms research (4 papers). The work is most often cited by research in Pharmacology (90 citations), Molecular Biology (543 citations) and Biotechnology (67 citations). Yamei Li has collaborated with scholars based in China, Saudi Arabia and Egypt. Frequent co-authors include Limei Lin, Bohou Xia, Duan‐Fang Liao, Lu Lv, Qingcui Wu, Jiaojiao Li, Ting Han, Yue Cui, Jianhua Wang and Peihao Chen. Their work appears in journals such as Analytical Chemistry, The FASEB Journal and Journal of Experimental Botany.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.